That abstract was written five years ago . It discusses lipophilicity of such compounds as isoniazid and fluconazole, which have long been used for treatment of diseases such as tuberculosis and vaginal yeast infections.
It would be interesting to know if any current study of mycobacteria and fungi look promising for CNS degenerative disease and cross the blood-brain barrier, and especially show proof of safety and efficacy.
- Forums
- ASX - By Stock
- ATH
- Investigating the activity spectrum for ring-substituted 8-hydroxyquinolines.
Investigating the activity spectrum for ring-substituted 8-hydroxyquinolines., page-2
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $9.838K | 3.277M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
75 | 100044686 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 157644647 | 64 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
75 | 100044686 | 0.002 |
26 | 140640147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 156344647 | 62 |
0.005 | 8366584 | 12 |
0.006 | 16581534 | 13 |
0.007 | 52264874 | 24 |
0.008 | 37620994 | 28 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online